Persistent URL of this record https://hdl.handle.net/1887/121520
In Collections
This item can be found in the following collections:
Duobody-CD3xCD20 Shows Unique and Potent Preclinical Anti-Tumor Activity in Vitro and In Vivo, and Is Being Evaluated Clinically in Patients with B-Cell Malignancies
- All authors
- Hiemstra, I.H.; Engelberts, P.J.; Jong, B. de; Schuurhuis, D.H.; Salcedo, T.W.; Verploegen, S.; Zee, M. van der; Gerritsen, A.F.; Losic, N.; Horbach, S.; Oliveri, R.; Bueren, J.J.L. van; Usher, P.A.; Schuurman, J.; Parren, P.W.H.I.; Breij, E.C.W.
- Date
- 2018-11-29
- Title of host publication
- Blood
- Volume
- 132